tiprankstipranks
Context Therapeutics (CNTX)
NASDAQ:CNTX

Context Therapeutics (CNTX) Ownership - Who Owns Context Therapeutics?

40 Followers

Context Therapeutics (CNTX) Ownership Overview

7.38%4.99%20.05%67.57%
7.38%
Insiders
20.05% Other Institutional Investors
67.57% Public Companies and
Individual Investors
The ownership structure of Context Therapeutics (CNTX) stock is a mix of institutional, retail and individual investors. Approximately 25.05% of the company’s stock is owned by Institutional Investors, 7.38% is owned by Insiders and 67.57% is owned by Public Companies and Individual Investors.
The ownership structure of Context Therapeutics (CNTX) stock is a mix of institutional, retail and individual investors. Approximately 25.05% of the company’s stock is owned by Institutional Investors, 7.38% is owned by Insiders and 67.57% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
598,303Institution3.75%843,607
596,012Institution3.73%840,377
105,809Institution0.66%149,191
95,595Institution0.60%134,789

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
596,012Institution3.73%840,377
105,809Institution0.66%149,191
95,595Institution0.60%134,789

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
573,400Institution3.59%791,292
24,903Institution0.16%34,366

FAQ

Who Owns Context Therapeutics (CNTX)?
According to the latest TipRanks data, approximately 20.05% of the company's stock is held by institutional investors, 7.38% is held by insiders, and 67.57% is held by retail investors.
    What percentage of Context Therapeutics (CNTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 20.05% of Context Therapeutics (CNTX) stock is held by institutional investors.
      What percentage of Context Therapeutics (CNTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 67.57% of Context Therapeutics (CNTX) stock is held by retail investors.
        Who owns the most shares of Context Therapeutics (CNTX)?
        Vanguard owns the most shares of Context Therapeutics (CNTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis